Begin main content

Magnetic Resonance Imaging for Pituitary Adenoma Detection in Patients with Hyperprolactinemia: Clinical Utility, Cost-Effectiveness and Guidelines

Last updated: June 30, 2016
Project Number: RA0854-000
Product Line: Rapid Response
Research Type: Other Diagnostics
Report Type: Reference List
Result type: Report

Question

  1. What is the clinical utility of using magnetic resonance imaging (MRI) for tumour detection in patients presenting with hyperprolactinemia?
  2. What is the cost-effectiveness of using MRI for tumour detection in patients presenting with hyperprolactinemia?
  3. What are the evidence-based guidelines regarding appropriate indications and clinical criteria for conducting MRI screening on patients presenting with hyperprolactinemia?
  4. What are the evidence-based guidelines regarding the clinical evaluation and diagnostic assessment of patients presenting with hyperprolactinemia?

Key Message

One non-randomized study was identified regarding the clinical utility of using MRI for tumour detection in patients presenting with hyperprolactinemia. In addition, two evidence-based guidelines were identified relating to the appropriate clinical evaluation and diagnostic assessment of patients presenting with hyperprolactinemia.